WALGREENS BOOTS ALLIANCE, INC.

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "WALGREENS BOOTS ALLIANCE, INC."

Transcription

1 WALGREENS BOOTS ALLIANCE, INC. FORM 8-K (Current report filing) Filed 08/04/15 for the Period Ending 07/29/15 Address 108 WILMOT ROAD DEERFIELD, IL Telephone (847) CIK Symbol WBA SIC Code Drug Stores and Proprietary Stores Industry Retail (Drugs) Sector Services Fiscal Year 08/31 Copyright 2015, EDGAR Online, Inc. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use.

2 SECURITIESANDEXCHANGECOMMISSION Washington,D.C FORM8-K CURRENTREPORT PursuanttoSection13or15(d) ofthesecuritiesexchangeactof1934 DateofReport(Dateofearliesteventreported):July29,2015 WALGREENSBOOTSALLIANCE,INC. (Exactnameofregistrantasspecifiedinitscharter) Delaware (Stateorotherjurisdiction (Commission (IRSEmployer ofincorporation) FileNumber) IdentificationNumber) 108WilmotRoad,Deerfield,Illinois (Addressofprincipalexecutiveoffices) (ZipCode) Registrant stelephonenumber,includingareacode:(847) NotApplicable (Formernameorformeraddress,ifchangedsincelastreport) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR e-4(c))

3 Item5.02.DepartureofDirectorsorCertainOfficers;ElectionofDirectors;AppointmentofCertainOfficers;CompensatoryArrangementsofCertain Officers. (b-c) On July 29, 2015, the Walgreens Boots Alliance, Inc. (the Company ) Board of Directors (the Board ) elected Kimberly R. Scardino as Senior Vice President, Global Controller and Chief Accounting Officer of the Company effective August 3, Pursuant to the Company s amended and restated by-laws, the Controller serves as the Company s principal accounting officer. Ms. Scardino will succeed George R. Fairweather as the Company s principal accounting officer. Mr. Fairweather will continue in his role as the Company s Executive Vice President and Global Chief Financial Officer. Ms. Scardino, age 44, served American Express Company as Senior Vice President, Business Advisory Controller from March 2015 to July 2015 and as Senior Vice President, Americas Controller, from June 2012 to March Previously, she served in roles of increasing responsibility at American Express Company and its subsidiaries, including as Vice President and Chief Accounting Officer of American Express Credit Corp. from December 2009 to June 2012 as well as Vice President, Global Head of SOX Compliance. Prior to joining American Express in 2006, Ms. Scardino served in accounting functions at Credit Suisse from 2004 to 2006 and at Lyondell Chemical Company from 2002 to Ms. Scardino started her career at Arthur Andersen LLP, where she was an auditor from 1994 to The Company entered into an employment offer letter with Ms. Scardino, which was approved by the Compensation Committee of the Board. The letter has no specified term, and her employment with the Company will be on an at-will basis. Her initial annualized base salary will be $425,000, and she will be eligible for an annual bonus (prorated in the case of the current fiscal year) under the Company s corporate bonus plan. Ms. Scardino also will be eligible to participate in the Company s stock-based incentive programs, which currently provide for stock option, restricted stock unit and performance share grants, and the Executive Severance and Change in Control Plan described in the Company s Proxy Statement filed with the Securities and Exchange Commission on April 17, She will also receive certain sign-on/retention bonuses, relocation assistance, initial equity awards and other benefits on the terms and conditions described in the offer letter. The foregoing summary is qualified in its entirety by reference to the full text of the offer letter agreement with Ms. Scardino, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference. There are no arrangements or understandings between Ms. Scardino and any other persons pursuant to which she was elected as an officer of the Company, she has no family relationships with any of the Company s directors or executive officers, and she is not a party to, and she does not have any direct or indirect material interest in, any transaction requiring disclosure under Item 404(a) of Regulation S-K. Item9.01. (d) Exhibits FinancialStatementsandExhibits. Exhibit Description 10.1 Offer letter agreement between Kimberly R. Scardino and Walgreens Boots Alliance, Inc.

4 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WALGREENS BOOTS ALLIANCE, INC. Date: August 4, 2015 By: /s/ Jan Stern Reed Title: Senior Vice President, General Counsel and Corporate Secretary

5 Exhibit10.1 Walgreens Boots Alliance, Inc. 102 Wilmot Road Deerfield, IL wba.com June 22, 2015 Ms. Kimberly Scardino [Address] Dear Kimberly, We are pleased to offer you the position of Senior Vice President, Global Controller and Chief Accounting Officer, currently under the management of George Fairweather. We hope you will find your employment with Walgreens Boots Alliance, Inc. ( WBA or the Company ) both challenging and rewarding and we look forward to you joining our team. As a U.S.-based team member working at the WBA group level, your employer for payroll, benefits and tax (W-2) purposes will be within the Walgreen Co. U.S. family of companies. The terms of this offer are subject to the final approval of the Compensation Committee of the Board of Directors of WBA. Below are the terms of your offer: BaseSalary.Your starting salary will be $425,000 annually, less all applicable tax withholdings and benefit deductions. AnnualBonusOpportunity.Based on your position, you will be eligible for annual bonuses under the WBA corporate bonus program, which is based on the Company s fiscal year running from September 1 through August 31. You would be eligible for a pro-rated bonus for the remainder of the current fiscal year. The current bonus target for your position is 70% of your eligible earnings. Your actual bonus each year is subject to Company performance and your individual performance, and all bonuses are subject to the discretion and approval of the Compensation Committee of our Board of Directors. Long-TermIncentiveOpportunity.You will also be eligible for long-term incentives granted under the terms and conditions of the WBA 2013 Omnibus Incentive Plan ( Omnibus Plan ). You will be eligible for market-competitive award levels granted at the discretion of the Compensation Committee of our Board of Directors. For your position, long-term incentives currently consist of a combination of stock options, restricted stock units and performance shares, with a combined target award equal in economic value to approximately $700,000 annually. In making award decisions each year, the Compensation Committee considers target award levels, budget levels, relative individual performance, and other factors. The design of WBA long-term incentive programs is currently under review, and will be communicated to you in connection with awards granted in the fall for Fiscal Year OtherCompensation. In consideration for your current compensation levels and outstanding equity awards from your current employer, you will receive the following sign-on incentives: A cash sign-on/retention bonus of $350,000. This will be paid in three installments, as follows: $150,000 following your date of hire, and $100,000 following each of the first and second anniversaries of date of hire. Each installment will be paid as soon as practicable after the aforementioned dates and will be subject to normal tax withholding. These bonuses will be subject to the terms and conditions of a retention bonus agreement that you will be required to sign as a condition to this benefit. In particular, this agreement will spell out that your continued employment is required in order to

6 Ms. Kimberly Scardino Page 2 June 22, 2015 receive each installment payment and if you voluntarily leave the Company or you are involuntarily terminated for cause within two years of an installment payment date you will be required to reimburse the Company for the full amount of that installment payment. An additional cash sign-on/retention bonus of $325,000 intended to replace a portion of your unvested equity that would have vested within the first two years of your employment. This payment will be made in two installments, the first $150,000 will be paid as soon as practicable after your date of hire and the second installment of $175,000 will be paid as soon as practicable following the first anniversary of your date of hire. Both installments will be subject to normal tax withholding. These bonuses will be subject to the terms and conditions of a retention bonus agreement that you will be required to sign as a condition to this benefit. In particular, this agreement will spell out that your continued employment is required in order to receive the payments and if you voluntarily leave the Company or you are involuntarily terminated for cause within one year of each payment date you will be required to reimburse the Company for the full amount of that installment payment. An equity award of stock options equal in economic value to $530,000 in total. This award will be provided (assuming continued employment through the grant date) on the first day of the WBA fiscal quarter following your date of hire. The exercise price will be the WBA closing price on the date of grant. The grant will vest in thirds, one-third after each of the first, second and third anniversaries of the date of grant. This stock option award will be subject to the terms and conditions of the WBA 2013 Omnibus Incentive Plan and the applicable award agreement. An additional equity award of stock options equal in economic value to $285,000 in total. This award will be provided (assuming continued employment through the grant date) on the first day of the WBA fiscal quarter following your date of hire. The exercise price will be the WBA closing price on the date of grant. The grant will vest on the third anniversary of the date of grant. The stock option award will be subject to the terms and conditions of the WBA 2013 Omnibus Incentive Plan and the applicable award agreement. OtherEmployeeBenefits. See the attached Overview of Management Benefits, briefly describing the employee benefits that are applicable. This includes paidtime off (PTO) equal to an annual benefit of 25 days (200 hours), which will begin accruing from your date of hire. As a U.S.-based team member, these other employee benefit programs applicable to you are primarily provided under Walgreen Co. plans and programs. Relocation.You will be eligible for relocation benefits in accordance with Company policy for management employees. Upon offer acceptance, a member of our Employee Services Department will be in contact with you to walk you through the details and process. Non-Compete. As a condition to this offer of employment, you will be required to sign a Non-Competition, Non-Solicitation and Confidentiality Agreement when you begin employment with WBA. This is a standard agreement, with certain terms tailored to your area and position. A copy of this Agreement can be provided in advance upon request. A similar agreement may also be included as part of long-term equity award agreements.

7 Ms. Kimberly Scardino Page 3 June 22, 2015 Your start date is to be determined. On your first day, please bring proof of your identity and eligibility for employment, a list of acceptable documents is enclosed. Please note that WBA, in an effort to maintain our strong sense of pride in the way we conduct our business, requires all employees to dress in business professional attire while at work or on travel representing the company. Our offer of employment will remain open for seven days from the date of this letter, and is contingent on your passing a pre-employment applicant background check and a pre-employment drug screen under our Drug Free Work Place Policy. It is our policy that the pre-employment drug screen test be completed within 48 hours of receiving this offer packet. You can find your nearest drug testing location by calling Enclosed are the Forensic Drug Testing Custody and Control Form and the Walgreens Drug Test Consent/Release Form. Please complete and return the consent/release form with the offer letter. Please bring the Forensic Drug Testing Custody and Control Form with you to the drug test facility along with a valid photo I.D. accepted by the state. If you want to accept this offer of employment, please sign your name on the line below, fill in the date, and return the signed letter in the enclosed envelope. The duplicate of this letter is for your records. By signing below, you are confirming that no actual breach, threatened breach or other violation of any past, current or contemplated oral or written contractual arrangement to which you are a party (including, but not limited to, any non-compete, non-solicitation or confidentiality agreement with any former employer) has or will occur by virtue of your acceptance of this offer of employment or your performing services for WBA. You should not consider our offer of employment to be a contract or guarantee of indefinite employment. Employment at WBA is at will, for no definite term, and is subject to WBA policies and total rewards plans and programs, which can all be changed from time to time. Further, WBA reserves the right to rescind the offer or terminate employment if a breach, threatened breach or other violation has or will occur and accordingly, you will not be eligible for WBA benefits upon termination. If you have any questions please call me at 0044 (0) Sincerely, /s/ Lisa Hare Lisa Hare Vice President, International Talent, Learning & Organizational Effectiveness Walgreens Boots Alliance, Inc.

8 Ms. Kimberly Scardino Page 4 June 22, 2015 Enclosures cc: George Fairweather Kathleen Wilson-Thompson I accept the offer of employment and understand that the offer is not intended to be a guarantee of continued employment. Name: /s/ Kimberly R. Scardino Date: 6/29/2015

NEVRO CORP FORM 8-K. (Current report filing) Filed 04/09/15 for the Period Ending 04/09/15

NEVRO CORP FORM 8-K. (Current report filing) Filed 04/09/15 for the Period Ending 04/09/15 NEVRO CORP FORM 8-K (Current report filing) Filed 04/09/15 for the Period Ending 04/09/15 Address 4040 CAMPBELL AVENUE SUITE 210 MENLO PARK, CA 94025 Telephone 650-251-0005 CIK 0001444380 Symbol NVRO SIC

More information

APPLE INC FORM 8-K. (Current report filing) Filed 06/06/14 for the Period Ending 06/06/14

APPLE INC FORM 8-K. (Current report filing) Filed 06/06/14 for the Period Ending 06/06/14 APPLE INC FORM 8-K (Current report filing) Filed 06/06/14 for the Period Ending 06/06/14 Address ONE INFINITE LOOP CUPERTINO, CA 95014 Telephone (408) 996-1010 CIK 0000320193 Symbol AAPL SIC Code 3571

More information

CME GROUP INC. FORM 8-K. (Current report filing) Filed 10/03/14 for the Period Ending 09/30/14

CME GROUP INC. FORM 8-K. (Current report filing) Filed 10/03/14 for the Period Ending 09/30/14 CME GROUP INC. FORM 8-K (Current report filing) Filed 10/03/14 for the Period Ending 09/30/14 Address 20 S. WACKER DR CHICAGO, IL 60606 Telephone 3129301000 CIK 0001156375 Symbol CME SIC Code 6200 - Security

More information

NEWS CORP FORM 8-K. (Current report filing) Filed 01/15/16 for the Period Ending 01/15/16

NEWS CORP FORM 8-K. (Current report filing) Filed 01/15/16 for the Period Ending 01/15/16 NEWS CORP FORM 8-K (Current report filing) Filed 01/15/16 for the Period Ending 01/15/16 Address 1211 AVENUE OF THE AMERICAS NEW YORK, NY 10036 Telephone 212-416-3400 CIK 0001564708 Symbol NWS SIC Code

More information

National American University Holdings, Inc.

National American University Holdings, Inc. SECURITIES & EXCHANGE COMMISSION EDGAR FILING National American University Holdings, Inc. Form: 8-K Date Filed: 2015-08-13 Corporate Issuer CIK: 1399855 Copyright 2015, Issuer Direct Corporation. All Right

More information

VISA INC. FORM 8-K. (Current report filing) Filed 02/27/15 for the Period Ending 02/27/15

VISA INC. FORM 8-K. (Current report filing) Filed 02/27/15 for the Period Ending 02/27/15 FORM 8-K (Current report filing) Filed 02/27/15 for the Period Ending 02/27/15 Address P.O. BOX 8999 SAN FRANCISCO, CA 94128-8999 Telephone (415) 932-2100 CIK 0001403161 Symbol V SIC Code 7389 - Business

More information

QUALCOMM INC/DE FORM 8-K. (Current report filing) Filed 09/30/15 for the Period Ending 09/28/15

QUALCOMM INC/DE FORM 8-K. (Current report filing) Filed 09/30/15 for the Period Ending 09/28/15 QUALCOMM INC/DE FORM 8-K (Current report filing) Filed 09/30/15 for the Period Ending 09/28/15 Address 5775 MOREHOUSE DR SAN DIEGO, CA 92121 Telephone 8585871121 CIK 0000804328 Symbol QCOM SIC Code 3663

More information

ANALOG DEVICES INC FORM 8-K. (Current report filing) Filed 06/18/15 for the Period Ending 06/17/15

ANALOG DEVICES INC FORM 8-K. (Current report filing) Filed 06/18/15 for the Period Ending 06/17/15 ANALOG DEVICES INC FORM 8-K (Current report filing) Filed 06/18/15 for the Period Ending 06/17/15 Address ONE TECHNOLOGY WAY NORWOOD, MA 02062 Telephone 7813294700 CIK 0000006281 Symbol ADI SIC Code 3674

More information

NORTHROP GRUMMAN CORP /DE/

NORTHROP GRUMMAN CORP /DE/ NORTHROP GRUMMAN CORP /DE/ FORM 8-K (Current report filing) Filed 02/07/13 for the Period Ending 02/06/13 Address 2980 FAIRVIEW PARK DRIVE C/O NORTHROP GRUMMAN CORP FALLS CHURCH, VA 22042 Telephone 703-280-2900

More information

SEQUENTIAL BRANDS GROUP, INC.

SEQUENTIAL BRANDS GROUP, INC. SEQUENTIAL BRANDS GROUP, INC. FORM 8-K (Current report filing) Filed 08/03/10 for the Period Ending 07/28/10 Address 1065 AVENUE OF AMERICAS SUITE 1705 NEW YORK, NY 10018 Telephone 213-745-2123 CIK 0000791770

More information

ABM INDUSTRIES INC /DE/

ABM INDUSTRIES INC /DE/ ABM INDUSTRIES INC /DE/ FORM 8-K (Current report filing) Filed 10/14/11 for the Period Ending 10/11/11 Address 551 FIFTH AVENUE SUITE 300 NEW YORK, NY 10176 Telephone 212 297-0200 CIK 0000771497 Symbol

More information

GSV CAPITAL CORP. FORM 8-K. (Current report filing) Filed 04/28/15 for the Period Ending 04/28/15

GSV CAPITAL CORP. FORM 8-K. (Current report filing) Filed 04/28/15 for the Period Ending 04/28/15 GSV CAPITAL CORP. FORM 8-K (Current report filing) Filed 04/28/15 for the Period Ending 04/28/15 Address 2925 WOODSIDE ROAD WOODSIDE, CA 94062 Telephone (650) 235-4777 CIK 0001509470 Symbol GSVC Industry

More information

MOTOROLA SOLUTIONS, INC.

MOTOROLA SOLUTIONS, INC. MOTOROLA SOLUTIONS, INC. FORM 8-K (Current report filing) Filed 06/14/13 for the Period Ending 06/13/13 Address 1303 E ALGONQUIN RD SCHAUMBURG, IL 60196 Telephone 8475765000 CIK 0000068505 Symbol MSI SIC

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

HUDSON CITY BANCORP INC Filed by M&T BANK CORP

HUDSON CITY BANCORP INC Filed by M&T BANK CORP HUDSON CITY BANCORP INC Filed by M&T BANK CORP FORM 425 (Filing of certain prospectuses and communications in connection with business combination transactions) Filed 04/15/13 Address WEST 80 CENTURY RD

More information

BRIDGEPOINT EDUCATION INC

BRIDGEPOINT EDUCATION INC BRIDGEPOINT EDUCATION INC FORM 8-K (Current report filing) Filed 11/12/13 for the Period Ending 11/08/13 Address 13500 EVENING CREEK DR. #600 SAN DIEGO, CA 92128 Telephone 858-668-2586 CIK 0001305323 Symbol

More information

PACIFIC ETHANOL, INC. (Exact name of registrant as specified in its charter)

PACIFIC ETHANOL, INC. (Exact name of registrant as specified in its charter) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported)

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) the Securities Exchange Act 1934 Date Report (Date Earliest Event Reported):

More information

HONG KONG HIGHPOWER TECHNOLOGY, INC.

HONG KONG HIGHPOWER TECHNOLOGY, INC. HONG KONG HIGHPOWER TECHNOLOGY, INC. FORM 8-K (Current report filing) Filed 01/28/09 for the Period Ending 01/28/09 Telephone 86 755 896 86238 CIK 0001368308 Symbol HPJ SIC Code 3690 - Miscellaneous Electrical

More information

STARZ FORM 8-K. (Current report filing) Filed 06/27/16 for the Period Ending 06/16/16

STARZ FORM 8-K. (Current report filing) Filed 06/27/16 for the Period Ending 06/16/16 STARZ FORM 8-K (Current report filing) Filed 06/27/16 for the Period Ending 06/16/16 Address 8900 LIBERTY CIRCLE ENGLEWOOD, CO 80112 Telephone (720) 852-7700 CIK 0001507934 Symbol STRZA SIC Code 4841 -

More information

IDEXX LABORATORIES, INC.

IDEXX LABORATORIES, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

Form: Action by Unanimous Written Consent of the Board of Directors in Lieu of Organizational Meeting (Delaware Corporation) Description:

Form: Action by Unanimous Written Consent of the Board of Directors in Lieu of Organizational Meeting (Delaware Corporation) Description: Form: Description: Action by Unanimous Written Consent of the Board of Directors in Lieu of Organizational Meeting (Delaware Corporation) A form of written consent of the board of directors of a Delaware

More information

Delaware 000-50703 14-1839426 (State or other jurisdiction of incorporation)

Delaware 000-50703 14-1839426 (State or other jurisdiction of incorporation) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 16, 2014 (Date

More information

SECURITIES AND EXCHANGE COMMISSION FORM 8-K GENSPERA, INC.

SECURITIES AND EXCHANGE COMMISSION FORM 8-K GENSPERA, INC. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

GULFPORT ENERGY CORPORATION

GULFPORT ENERGY CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities exchange act of 1934 Date of report (Date of earliest event

More information

WALGREEN CO FORM 8-K. (Current report filing) Filed 08/04/14 for the Period Ending 07/30/14

WALGREEN CO FORM 8-K. (Current report filing) Filed 08/04/14 for the Period Ending 07/30/14 WALGREEN CO FORM 8-K (Current report filing) Filed 08/04/14 for the Period Ending 07/30/14 Address 108 WILMOT RD DEERFIELD, IL 60015 Telephone 8479402500 CIK 0000104207 Symbol WAG SIC Code 5912 - Drug

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K ABBVIE INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K ABBVIE INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

CERIDIAN CORPORATION

CERIDIAN CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

FORM 8-K. CREATIVE REALITIES, INC. (Exact name of registrant as specified in its charter)

FORM 8-K. CREATIVE REALITIES, INC. (Exact name of registrant as specified in its charter) 8-K 1 f8k091514_creativerealities.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE

More information

NVIDIA CORP FORM 8-K. (Current report filing) Filed 05/26/15 for the Period Ending 05/20/15

NVIDIA CORP FORM 8-K. (Current report filing) Filed 05/26/15 for the Period Ending 05/20/15 NVIDIA CORP FORM 8-K (Current report filing) Filed 05/26/15 for the Period Ending 05/20/15 Address 2701 SAN TOMAS EXPRESSWAY SANTA CLARA, CA 95050 Telephone 408-486-2000 CIK 0001045810 Symbol NVDA SIC

More information

HOME LOAN SERVICING SOLUTIONS, LTD.

HOME LOAN SERVICING SOLUTIONS, LTD. HOME LOAN SERVICING SOLUTIONS, LTD. FORM DEFA14A (Additional Proxy Soliciting Materials (definitive)) Filed 04/24/15 Telephone (345) 945-3727 CIK 0001513161 Symbol HLSS SIC Code 6162 - Mortgage Bankers

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 13, 2012 Date

More information

AMERUS GROUP CO/IA. FORM 8-K (Current report filing) Filed 8/15/2006 For Period Ending 8/14/2006

AMERUS GROUP CO/IA. FORM 8-K (Current report filing) Filed 8/15/2006 For Period Ending 8/14/2006 AMERUS GROUP CO/IA FORM 8-K (Current report filing) Filed 8/15/2006 For Period Ending 8/14/2006 Address 699 WALNUT STREET DES MOINES, Iowa 50309 Telephone 515-362-3600 CIK 0001051717 Industry Insurance

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K

UNITED STATES. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Page 1 of 10 8-K 1 a8k06022014.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of

More information

CHINA BIOLOGIC PRODUCTS, INC.

CHINA BIOLOGIC PRODUCTS, INC. CHINA BIOLOGIC PRODUCTS, INC. FORM 8-K (Current report filing) Filed 04/25/12 for the Period Ending 04/25/12 Telephone 86-10-6598-3111 CIK 0001369868 Symbol CBPO SIC Code 2836 - Biological Products, Except

More information

BOOZ ALLEN HAMILTON HOLDING CORP

BOOZ ALLEN HAMILTON HOLDING CORP BOOZ ALLEN HAMILTON HOLDING CORP FORM 8-K (Current report filing) Filed 01/31/14 for the Period Ending 01/31/14 Address 8283 GREENSBORO DRIVE MCLEAN, VA 22102 Telephone 703-902-5000 CIK 0001443646 Symbol

More information

EDWARDS LIFESCIENCES CORP

EDWARDS LIFESCIENCES CORP EDWARDS LIFESCIENCES CORP FORM 8-K (Current report filing) Filed 11/14/14 for the Period Ending 11/13/14 Address ONE EDWARDS WAY IRVINE, CA 92614 Telephone 9492502500 CIK 0001099800 Symbol EW SIC Code

More information

SECURITIES AND EXCHANGE COMMISSION FORM 8-K. Current report filing

SECURITIES AND EXCHANGE COMMISSION FORM 8-K. Current report filing SECURITIES AND EXCHANGE COMMISSION FORM 8-K Current report filing Filing Date: 2005-11-07 Period of Report: 2005-11-01 SEC Accession No. 0000950137-05-013397 (HTML Version on secdatabase.com) FILER PRINCIPAL

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest

More information

FORM 8-K. FIFTH THIRD BANCORP - fitb. Filed: November 12, 2008 (period: November 07, 2008) Report of unscheduled material events or corporate changes.

FORM 8-K. FIFTH THIRD BANCORP - fitb. Filed: November 12, 2008 (period: November 07, 2008) Report of unscheduled material events or corporate changes. FORM 8-K FIFTH THIRD BANCORP - fitb Filed: November 12, 2008 (period: November 07, 2008) Report of unscheduled material events or corporate changes. 8-K - CURRENT REPORT Table of Contents Item 1.01 Entry

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A AMENDMENT #1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A AMENDMENT #1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A AMENDMENT #1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date

More information

GLOBAL DEFENSE & NATIONAL SECURITY SYSTEMS, INC.

GLOBAL DEFENSE & NATIONAL SECURITY SYSTEMS, INC. GLOBAL DEFENSE & NATIONAL SECURITY SYSTEMS, INC. FORM DEFA14A (Additional Proxy Soliciting Materials (definitive)) Filed 07/14/15 Address 11921 FREEDOM DRIVE, SUITE 550 TWO FOUNTAIN SQUARE RESTON, VA 20190

More information

VOLTARI CORP FORM 8-K. (Current report filing) Filed 05/27/14 for the Period Ending 05/20/14

VOLTARI CORP FORM 8-K. (Current report filing) Filed 05/27/14 for the Period Ending 05/20/14 VOLTARI CORP FORM 8-K (Current report filing) Filed 05/27/14 for the Period Ending 05/20/14 Address 601 WEST 26TH STREET SUITE 415 NEW YORK, NY 10001 Telephone 212-792-9671 CIK 0001568319 Symbol VLTC SIC

More information

SOLARCITY CORP FORM 8-K. (Current report filing) Filed 10/29/15 for the Period Ending 10/29/15

SOLARCITY CORP FORM 8-K. (Current report filing) Filed 10/29/15 for the Period Ending 10/29/15 SOLARCITY CORP FORM 8-K (Current report filing) Filed 10/29/15 for the Period Ending 10/29/15 Address 3055 CLEARVIEW WAY SAN MATEO, CA 94402 Telephone 650-638-1028 CIK 0001408356 Symbol SCTY SIC Code 1700

More information

FEDERAL DEPOSIT INSURANCE CORPORATION. Washington, D.C FORM 8-K CURRENT REPORT. PURSUANT TO SECTION 13 OR 15(d)

FEDERAL DEPOSIT INSURANCE CORPORATION. Washington, D.C FORM 8-K CURRENT REPORT. PURSUANT TO SECTION 13 OR 15(d) FEDERAL DEPOSIT INSURANCE CORPORATION Washington, D.C. 20429 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):

More information

ARIAD Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter)

ARIAD Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

DIFFUSION PHARMACEUTICALS INC.

DIFFUSION PHARMACEUTICALS INC. DIFFUSION PHARMACEUTICALS INC. FORM 8-K (Current report filing) Filed 03/07/14 for the Period Ending 03/07/14 Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE, VA 22902 Telephone (434) 220-0718 CIK 0001053691

More information

MICROSOFT CORP FORM 8-K. (Current report filing) Filed 09/29/15 for the Period Ending 09/29/15

MICROSOFT CORP FORM 8-K. (Current report filing) Filed 09/29/15 for the Period Ending 09/29/15 MICROSOFT CORP FORM 8-K (Current report filing) Filed 09/29/15 for the Period Ending 09/29/15 Address ONE MICROSOFT WAY REDMOND, WA 98052-6399 Telephone 4258828080 CIK 0000789019 Symbol MSFT SIC Code 7372

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

INFOSPACE INC FORM 8-K. (Current report filing) Filed 12/21/06 for the Period Ending 12/21/06

INFOSPACE INC FORM 8-K. (Current report filing) Filed 12/21/06 for the Period Ending 12/21/06 INFOSPACE INC FORM 8-K (Current report filing) Filed 12/21/06 for the Period Ending 12/21/06 Address 601 108TH AVE NE SUITE 1200 BELLEVUE, WA 98004 Telephone 4258821602 CIK 0001068875 Symbol INSP SIC Code

More information

UNITED THERAPEUTICS CORP

UNITED THERAPEUTICS CORP UNITED THERAPEUTICS CORP FORM 8-K (Current report filing) Filed 11/13/14 for the Period Ending 11/11/14 Address 1040 SPRING ST SILVER SPRING, MD 20910 Telephone 3016089292 CIK 0001082554 Symbol UTHR SIC

More information

IMPERIAL HOLDINGS, INC.

IMPERIAL HOLDINGS, INC. IMPERIAL HOLDINGS, INC. FORM 8-K (Current report filing) Filed 01/03/12 for the Period Ending 12/30/11 Address 701 PARK OF COMMERCE BOULEVARD SUITE 301 BOCA RATON, FL 33487 Telephone 561-995-4200 CIK 0001494448

More information

CONNECTICUT WATER SERVICE INC / CT

CONNECTICUT WATER SERVICE INC / CT CONNECTICUT WATER SERVICE INC / CT FORM 8-K (Current report filing) Filed 05/10/13 for the Period Ending 05/10/13 Address 93 W MAIN ST CLINTON, CT 06413 Telephone 8606698630 CIK 0000276209 Symbol CTWS

More information

For personal use only

For personal use only UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 15, 2012 Date of Report (Date

More information

BEAZER HOMES USA INC

BEAZER HOMES USA INC BEAZER HOMES USA INC FORM 8-A12B (Securities Registration (section 12(b))) Filed 07/16/12 Address 1000 ABERNATHY ROAD STE 260 ATLANTA, GA 30328 Telephone 7708293700 CIK 0000915840 Symbol BZH SIC Code 1531

More information

PRICE T ROWE GROUP INC

PRICE T ROWE GROUP INC PRICE T ROWE GROUP INC FORM 8-K (Current report filing) Filed 09/10/15 for the Period Ending 09/10/15 Address 100 EAST PRATT STREET P.O. BOX 89000 BALTIMORE, MD 21289-0320 Telephone 4103452000 CIK 0001113169

More information

Form 10-K/A. Synopsys, Inc. (Exact name of registrant as specified in its charter)

Form 10-K/A. Synopsys, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No. 1 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year

More information

DEVON ENERGY CORP/DE

DEVON ENERGY CORP/DE DEVON ENERGY CORP/DE FORM 8-K (Current report filing) Filed 12/08/14 for the Period Ending 12/03/14 Address 333 W. SHERIDAN AVENUE OKLAHOMA CITY, OK 73102 Telephone 4055528183 CIK 0001090012 Symbol DVN

More information

TIME WARNER CABLE INC. (TWC) 8-K. Current report filing Filed on 03/13/2009 Filed Period 03/12/2009

TIME WARNER CABLE INC. (TWC) 8-K. Current report filing Filed on 03/13/2009 Filed Period 03/12/2009 TIME WARNER CABLE INC. (TWC) 8-K Current report filing Filed on 03/13/2009 Filed Period 03/12/2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant

More information

INCONTACT, INC. FORM 8-K. (Current report filing) Filed 03/25/15 for the Period Ending 03/23/15

INCONTACT, INC. FORM 8-K. (Current report filing) Filed 03/25/15 for the Period Ending 03/23/15 INCONTACT, INC. FORM 8-K (Current report filing) Filed 03/25/15 for the Period Ending 03/23/15 Address 7730 S. UNION PARK AVE., SUITE 500 NONE MIDVALE, UT 84047 Telephone (801) 320-3300 CIK 0001087934

More information

ACTINIUM PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter)

ACTINIUM PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

SPHERIX INC FORM 8-K. (Current report filing) Filed 05/24/16 for the Period Ending 05/23/16

SPHERIX INC FORM 8-K. (Current report filing) Filed 05/24/16 for the Period Ending 05/23/16 SPHERIX INC FORM 8-K (Current report filing) Filed 05/24/16 for the Period Ending 05/23/16 Address 1350 AVENUE OF THE AMERICAS FL 2 NEW YORK, NY 10019 Telephone 347-321-7646 CIK 0000012239 Symbol SPEX

More information

FORUM ENERGY TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter)

FORUM ENERGY TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

YEW BIO-PHARM GROUP, INC.

YEW BIO-PHARM GROUP, INC. YEW BIO-PHARM GROUP, INC. FORM 8-K (Current report filing) Filed 04/30/13 for the Period Ending 04/30/13 Address 294 POWERBILT AVENUE LAS VEGAS, NV 89148 Telephone 86-0451-82292379 CIK 0001548240 Symbol

More information

MVC CAPITAL, INC. FORM 8-K. (Current report filing) Filed 07/06/15 for the Period Ending 06/29/15

MVC CAPITAL, INC. FORM 8-K. (Current report filing) Filed 07/06/15 for the Period Ending 06/29/15 MVC CAPITAL, INC. FORM 8-K (Current report filing) Filed 07/06/15 for the Period Ending 06/29/15 Address RIVERVIEW AT PURCHASE 287 BOWMAN AVENUE, 3RD FLOOR PURCHASE, NY 10577 Telephone 914-701-0310 CIK

More information

RAYTHEON COMPANY (Exact name of registrant as specified in its charter)

RAYTHEON COMPANY (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event

More information

CITADEL BROADCASTING CORP Filed by CUMULUS MEDIA INC

CITADEL BROADCASTING CORP Filed by CUMULUS MEDIA INC CITADEL BROADCASTING CORP Filed by CUMULUS MEDIA INC FORM 425 (Filing of certain prospectuses and communications in connection with business combination transactions) Filed 08/25/11 Address 7201 W LAKE

More information

IHEARTMEDIA CAPITAL I, LLC

IHEARTMEDIA CAPITAL I, LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

ALEXION PHARMACEUTICALS INC

ALEXION PHARMACEUTICALS INC ALEXION PHARMACEUTICALS INC FORM 8-K (Current report filing) Filed 04/07/15 for the Period Ending 04/01/15 Address 352 KNOTTER DRIVE CHESHIRE, CT 06511 Telephone 2037761790 CIK 0000899866 Symbol ALXN SIC

More information

JACOBS ENGINEERING GROUP INC /DE/

JACOBS ENGINEERING GROUP INC /DE/ JACOBS ENGINEERING GROUP INC /DE/ FORM 8-K (Current report filing) Filed 04/29/14 for the Period Ending 04/28/14 Address 155 NORTH LAKE AVENUE PASADENA, CA 91101 Telephone 6265783500 CIK 0000052988 Symbol

More information

FEDERATED NATIONAL HOLDING COMPANY (Exact name of registrant as specified in its charter)

FEDERATED NATIONAL HOLDING COMPANY (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 15, 2015 (Date

More information

IMS HEALTH HOLDINGS, INC.

IMS HEALTH HOLDINGS, INC. IMS HEALTH HOLDINGS, INC. FORM 8-K (Current report filing) Filed 06/30/14 for the Period Ending 06/30/14 Address 83 WOOSTER HEIGHTS ROAD DANBURY, CT 06810 Telephone 203-448-4600 CIK 0001595262 Symbol IMS

More information

SANTANDER DRIVE AUTO RECEIVABLES LLC

SANTANDER DRIVE AUTO RECEIVABLES LLC SANTANDER DRIVE AUTO RECEIVABLES LLC FORM 8-K (Current report filing) Filed 03/12/13 for the Period Ending 03/06/13 Address 8585 NORTH STEMMONS FREEWAY SUITE 1100-N DALLAS, TX 75247 Telephone 214-237-3530

More information

HANGER, INC. FORM 8-K. (Current report filing) Filed 05/12/14 for the Period Ending 05/07/14

HANGER, INC. FORM 8-K. (Current report filing) Filed 05/12/14 for the Period Ending 05/07/14 HANGER, INC. FORM 8-K (Current report filing) Filed 05/12/14 for the Period Ending 05/07/14 Address 10910 DOMAIN DRIVE, SUITE 300 AUSTIN, TX 78758 Telephone 512-777-3800 CIK 0000722723 Symbol HNGR SIC

More information

PLAINS ALL AMERICAN PIPELINE LP

PLAINS ALL AMERICAN PIPELINE LP PLAINS ALL AMERICAN PIPELINE LP FORM 8-K (Current report filing) Filed 01/09/15 for the Period Ending 01/09/15 Address 333 CLAY STREET SUITE 1600 HOUSTON, TX 77002 Telephone 7136544100 CIK 0001070423 Symbol

More information

NORDSON CORP FORM 8-K. (Current report filing) Filed 06/14/12 for the Period Ending 06/14/12

NORDSON CORP FORM 8-K. (Current report filing) Filed 06/14/12 for the Period Ending 06/14/12 NORDSON CORP FORM 8-K (Current report filing) Filed 06/14/12 for the Period Ending 06/14/12 Address 28601 CLEMENS RD WESTLAKE, OH 44145 Telephone 4408921580 CIK 0000072331 Symbol NDSN SIC Code 3569 - General

More information

FEDERAL DEPOSIT INSURANCE CORPORATION Washington, D.C. 20429 FORM 8-K. Summit State Bank (Exact name of registrant as specified in its charter)

FEDERAL DEPOSIT INSURANCE CORPORATION Washington, D.C. 20429 FORM 8-K. Summit State Bank (Exact name of registrant as specified in its charter) FEDERAL DEPOSIT INSURANCE CORPORATION Washington, D.C. 20429 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):

More information

TIME WARNER INC. FORM 8-K. (Current report filing) Filed 11/09/07 for the Period Ending 11/05/07

TIME WARNER INC. FORM 8-K. (Current report filing) Filed 11/09/07 for the Period Ending 11/05/07 TIME WARNER INC. FORM 8-K (Current report filing) Filed 11/09/07 for the Period Ending 11/05/07 Address ONE TIME WARNER CENTER NEW YORK, NY 10019 Telephone 2124848000 CIK 0001105705 Symbol TWX SIC Code

More information

NORTHERN TECHNOLOGIES INTERNATIONAL CORP Filed by INTER ALIA HOLDING CO

NORTHERN TECHNOLOGIES INTERNATIONAL CORP Filed by INTER ALIA HOLDING CO NORTHERN TECHNOLOGIES INTERNATIONAL CORP Filed by INTER ALIA HOLDING CO FORM SC 13D/A (Amended Statement of Beneficial Ownership) Filed 12/02/11 Address 4201 WOODLAND ROAD PO BOX 69 CIRCLE PINES, MN 55014

More information

MOOG INC. (Exact name of registrant as specified in its charter)

MOOG INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

Corinthian Colleges, Inc.

Corinthian Colleges, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event

More information

NAKED BRAND GROUP INC. (Exact name of registrant as specified in its charter)

NAKED BRAND GROUP INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

THE GOLDMAN SACHS GROUP, INC. (Exact name of registrant as specified in its charter)

THE GOLDMAN SACHS GROUP, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

http://www.orrick.com/practices/emerging-companies/startup-forms/pages/disclaimer.aspx

http://www.orrick.com/practices/emerging-companies/startup-forms/pages/disclaimer.aspx Orrick's Technology Companies Group Start-Up Forms Library The attached document is part of the Start-Up Forms Library provided by Orrick's Technology Companies Group. By using/viewing the attached document,

More information

CALGON CARBON CORP FORM 8-K. (Current report filing) Filed 04/04/11 for the Period Ending 03/31/11

CALGON CARBON CORP FORM 8-K. (Current report filing) Filed 04/04/11 for the Period Ending 03/31/11 CALGON CARBON CORP FORM 8-K (Current report filing) Filed 04/04/11 for the Period Ending 03/31/11 Address 3000 GSK DRIVE MOON TOWNSHIP, PA 15018 Telephone 4127876700 CIK 0000812701 Symbol CCC SIC Code

More information

General Cable Corporation (Exact name of registrant as specified in its charter)

General Cable Corporation (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest

More information

TECO ENERGY INC FORM 8-K. (Current report filing) Filed 09/03/14 for the Period Ending 09/02/14

TECO ENERGY INC FORM 8-K. (Current report filing) Filed 09/03/14 for the Period Ending 09/02/14 TECO ENERGY INC FORM 8-K (Current report filing) Filed 09/03/14 for the Period Ending 09/02/14 Address 702 N FRANKLIN ST TECO PLAZA TAMPA, FL 33602 Telephone 8132284111 CIK 0000350563 Symbol TE SIC Code

More information

VECTOR GROUP LTD FORM 8-K. (Current report filing) Filed 07/30/14 for the Period Ending 07/30/14

VECTOR GROUP LTD FORM 8-K. (Current report filing) Filed 07/30/14 for the Period Ending 07/30/14 VECTOR GROUP LTD FORM 8-K (Current report filing) Filed 07/30/14 for the Period Ending 07/30/14 Address 4400 BISCAYNE BOULEVARD 10TH FLOOR MIAMI, FL 33137 Telephone 3055798000 CIK 0000059440 Symbol VGR

More information

STEINWAY MUSICAL INSTRUMENTS INC

STEINWAY MUSICAL INSTRUMENTS INC STEINWAY MUSICAL INSTRUMENTS INC FORM 8-K (Current report filing) Filed 12/26/12 for the Period Ending 12/20/12 Address 800 SOUTH STREET SUITE 305 WALTHAM, MA 02453-1472 Telephone 7818949770 CIK 0000911583

More information

FORM 8-K. BLACKHAWK CAPITAL GROUP BDC, INC. (Exact name of registrant as specified in its charter)

FORM 8-K. BLACKHAWK CAPITAL GROUP BDC, INC. (Exact name of registrant as specified in its charter) 8-K 1 v325271_8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date

More information

ONCOTHYREON INC. FORM 424B3. (Prospectus filed pursuant to Rule 424(b)(3)) Filed 12/22/10

ONCOTHYREON INC. FORM 424B3. (Prospectus filed pursuant to Rule 424(b)(3)) Filed 12/22/10 ONCOTHYREON INC. FORM 424B3 (Prospectus filed pursuant to Rule 424(b)(3)) Filed 12/22/10 Address 2601 FOURTH AVENUE SUITE 500 SEATTLE, WA 98121 Telephone (206) 801-2100 CIK 0001412067 Symbol ONTY SIC Code

More information

GARDNER DENVER INC FORM 8-K. (Current report filing) Filed 11/19/12 for the Period Ending 11/12/12

GARDNER DENVER INC FORM 8-K. (Current report filing) Filed 11/19/12 for the Period Ending 11/12/12 GARDNER DENVER INC FORM 8-K (Current report filing) Filed 11/19/12 for the Period Ending 11/12/12 Address 1500 LIBERTY RIDGE DRIVE, SUITE 3000 WAYNE, PA 19087 Telephone 6102492000 CIK 0000916459 SIC Code

More information

FEDERATED NATIONAL HOLDING COMPANY (Exact name of registrant as specified in its charter)

FEDERATED NATIONAL HOLDING COMPANY (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 9, 2014 (Date

More information

MARATHON OIL CORP FORM 8-K. (Current report filing) Filed 09/24/15 for the Period Ending 09/23/15

MARATHON OIL CORP FORM 8-K. (Current report filing) Filed 09/24/15 for the Period Ending 09/23/15 MARATHON OIL CORP FORM 8-K (Current report filing) Filed 09/24/15 for the Period Ending 09/23/15 Address P O BOX 3128 HOUSTON, TX 77253-3128 Telephone 7136296600 CIK 0000101778 Symbol MRO SIC Code 1311

More information

SORRENTO THERAPEUTICS, INC.

SORRENTO THERAPEUTICS, INC. ˆ200F@WVSVmdG1Yng+Š 200F@WVSVmdG1Yng+ AZ0151AC599817 11.3.10 SWRvelaj0nb 31-Jul-2013 16:51 EST 577580 TX 1 3* UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 CURRENT REPORT Pursuant

More information

NORDSON CORP FORM 8-K. (Current report filing) Filed 05/21/12 for the Period Ending 05/18/12

NORDSON CORP FORM 8-K. (Current report filing) Filed 05/21/12 for the Period Ending 05/18/12 NORDSON CORP FORM 8-K (Current report filing) Filed 05/21/12 for the Period Ending 05/18/12 Address 28601 CLEMENS RD WESTLAKE, OH 44145 Telephone 4408921580 CIK 0000072331 Symbol NDSN SIC Code 3569 - General

More information